Article citationsMore>>
Tachibana, K., Imaoka, I., Shiraishi, T., Yoshino, H., Nakamura, M., Ohta, M., Kawata, H., Taniguchi, K., Ishikura, N., Tsunenari, T., Saito, H., Nagamuta, M., Nakagawa, T., Takanashi, K., Onuma, E. and Sato, H. (2008) Discovery of an Orally-Active Nonsteroidal Androgen Receptor Pure Antagonist and the Structure-Activity Relationships of Its Derivatives. Chemical & Pharmaceutical Bulletin, 56, 1555-1561.
http://doi.org/10.1248/cpb.56.1555
has been cited by the following article:
-
TITLE:
Molecular Modeling, Docking and ADMET of Dimethylthiohydantoin Derivatives for Prostate Cancer Treatment
AUTHORS:
Khaled Lotfy
KEYWORDS:
Androgen Receptor, Prostate Cancer, Molecular Modeling, Molecular Docking, ADMET
JOURNAL NAME:
Journal of Biophysical Chemistry,
Vol.6 No.4,
November
4,
2015
ABSTRACT: In silico technique was applied to screen potential of 16 compounds of 5,5-dimethylthiohydantoin derivatives as androgen antagonist. The 3D structure of the protein was obtained from PDB database. Docking analysis of the compounds was performed using hex docking. Molecular modeling analysis exhibits relatively low LUMO-HOMO energy gap of the studied molecules, indicating that it would be kinetically stable. None of the compounds violated Lipinski’s parameters, making them potentially promising agents for biological activities. The title compounds exhibited the lowest docking energy of protein-ligand complex. Finally, the results indicate that these compounds are potentially as an androgen antagonist, and expected to be effective in prostate cancer treatment.
Related Articles:
-
Valerii Ermakov, Volodymyr Kolomoets, Leonid Panasyuk, Baja Orasgulyev
-
Andrew Beckwith
-
Tyler Downing, Amy Mangla, Michael Banta, Suguru Nakamura
-
Du Thanh Hang, Than Thi Thanh Tra, Le Minh Tuan, Geoffrey Peter Savage
-
Indra Rajasingh, Bharati Rajan, Ramanathan Sundara Rajan